AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises

Amedisys, Inc. (AMED) reported fourth-quarter 2024 adjusted earnings per share (EPS) of 96 cents, which rose 2.1% year over year. However, the metric missed the Zacks Consensus Estimate by 8.6%.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.The quarter’s adjustments include certain merger-related expenses and other (income)/expenses, net.GAAP loss was 62 cents per share against EPS of 59 cents in the corresponding period of 2023.Full-year 2024 adjusted EPS was $4.32, up 0.5% year ove ...